{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpolitico-audio-feed.simplecast.com%2Fepisodes%2Fthe-novavax-blame-game-xOrUycoG","width":444,"version":"1.0","type":"rich","title":"The Novavax blame game","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/c19de819-931e-4d07-823c-6cc5df3ecb2f/193b35b5-e3db-4f9f-9786-4f61106466d2/politico-logo-33.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/a130fb92-722b-491a-93ae-f31262b5bb87\" height=\"200\" width=\"100%\" title=\"The Novavax blame game\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"U.S. officials bet on Novavax to provide a shot that could easily be shipped overseas. But its manufacturing problems have left global distributors without enough shots for poor and middle-income countries. POLITICO's Erin Banco reports."}